NCT03477552

Transillumination Device for Peripheral Intravenous Placement in Patients With Sickle Cell Disease (PERFID)

Efficacy of AccuVein V400 to Facilitate Peripheral Intravenous Placement in Sickle Cell Disease Adults With Vaso-occlusive Crisis : a Randomized Clinical Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 126 (actual)
• Sponsor: Assistance Publique - Hôpitaux de Paris · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The primary goal of this randomized, controlled, open-label study is to determine the efficacy of AccuveinV400 (a transillumination veins device) to facilitate peripheral intravenous (IVP) catheter placement during a vaso-oclusive crisis. The investigators hypothesized that the number of attempts to a successful placement of a peripheral IV, our primary outcome, would be shorter with the assistance of the Accuvein V400. It is also expected that AccuveinV400 will reduce the time of the procedure, the rate of failure, the technique-related pain.

Conditions

• Sickle Cell Crisis

Interventions

Type	Name	Description
DEVICE	Accuvein V400 device	Sickle cell patients who need a new vein puncture in order to infuse them will benefit of AccuveinV400 device to illuminate their venous network
OTHER	Routine procedure	In the control group, the nurse proceeds as usual to infuse the patient (visual identification in the light of the chamber and palpation)

Timeline

• Start date: 2018-03-30
• Primary completion: 2022-04-30
• Completion: 2022-05-30
• First posted: 2018-03-26
• Last updated: 2023-01-13

Locations

2 sites across 1 country: France

Regulatory

• FDA-regulated device study